Advances in the natural α‐glucosidase inhibitors
eFood · 2023-10 · 4 (5)
DOI: 10.1002/efd2.112 ↗Kurz gefasst
Fachartikel in der Zeitschrift eFood, online erschienen am 12.09.2023. Verfasst von Didem Şöhretoğlu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
α‐Glucosidase (AG) inhibitors, one of the classes of oral antidiabetics used to treat type 2 diabetes mellitus, delay digestion and absorption of glucose, which in turn, has a lowering effect on postprandial blood glucose and insulin levels. Natural products are a great source for the development of new AG inhibitory drug candidates. We aim to summarize advances in natural AG inhibitors according to their secondary metabolite groups in the last decade. Their mechanisms of action and structure–activity relationships will especially be discussed.
Zitieren
APA
Şöhretoğlu, D., Renda, G., Arroo, R., Xiao, J., & Sari, S. (2023). Advances in the natural α‐glucosidase inhibitors. eFood, 4(5). https://doi.org/10.1002/efd2.112
Vancouver
Şöhretoğlu D, Renda G, Arroo R, Xiao J, Sari S. Advances in the natural α‐glucosidase inhibitors. eFood. 2023;4(5). doi:10.1002/efd2.112
BibTeX
@article{hretolu2023,
author = {Şöhretoğlu, Didem and Renda, Gülin and Arroo, Randolph and Xiao, Jianbo and Sari, Suat},
title = {Advances in the natural α‐glucosidase inhibitors},
journal = {eFood},
year = {2023},
volume = {4},
number = {5},
doi = {10.1002/efd2.112}
}
EUVIMED